Skip to main content
Premium Trial:

Request an Annual Quote

Sysmex Inostics, Bayer to Develop Companion Diagnostics for Cancer Therapies

NEW YORK (GenomeWeb News) — Sysmex Inostics said today that it has inked a collaboration agreement with Bayer Healthcare to develop blood-based companion diagnostics for targeted anti-cancer therapies being developed by Bayer.

Under the agreement, Sysmex Inostics, a subsidiary of Japanese in vitro diagnostics firm Sysmex, will develop blood-based diagnostic tests using its BEAMing technology, an ultra-sensitive digital PCR approach that can detect cancer cell DNA directly from blood.

The technology provides a non-invasive alternative to biopsies to obtain the mutational status of a patient's tumor — a so-called "liquid biopsy" that allows the selection of an appropriate therapeutic agent without the need of further surgeries or biopsies, and can be performed on patients where no tumor tissue is available, Sysmex Inostics said.

The companies did not disclose financial details of the agreement.

Inostics was founded in 2008 by Indivumed and Johns Hopkins University scientists, who invented the BEAMing technology. Sysmex acquired Inostics last month for an undisclosed amount.

Sysmex Inostics offers research and clinical diagnostic services based on BEAMing out of its Hamburg, Germany headquarters and its CLIA-licensed laboratory in Baltimore, Md.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.